Inventor

KELDENICH JOERG

DE70 patents

⚠️ This page may combine multiple inventors who share the name “KELDENICH JOERG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KELDENICH JOERG

BAYER AG

2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors

2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors

Biphenyl and biphenyl-analogous compounds as integrin antagonists

1,5-dihydro-pyrazolo[34-D]-pyrimidinone derivatives

Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases

Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases

2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension

Thiazolyl amide derivatives

Biphenyl and biphenyl-analogous compounds as integrin antagonists

Aryl sulphonamide amino acid esters and analogues

Thiazolyl urea derivatives and their utilization as antiviral agents

β-phenylalanine derivatives as integrin antagonists

Aryl sulphonamides and analogues

Process for breaking oil-in-water emulsions

Arylsulfonamides as antiviral agents

Arylsulphonamides and analogues

Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors

BAYER HEALTHCARE AG

Substituted dihydroquinazolines

2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors

Substituted imidazotriazines

2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors

Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes

1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use

Dihydropyridinone derivatives

Substituted 2-phenyl-3(2h)-pyridazinones

Hetrocyclic aryl sulphonamides

BAYER SCHERING PHARMA AG

Heterocyclic derivatives

Dihydropyridine derivatives for use as human neutrophil elastase inhibitors

2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors

2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses

Substituted quinazolines as antiviral agents, especially against cytomegaloviruses

Bayer Pharma AG

5-aminotetrahydroquinoline-2-carboxylic acids and their use

Substituted bipiperidinyl derivatives

5-aminotetrahydroquinoline-2-carboxylic acids and their use

5-aminotetrahydroquinoline-2-carboxylic acids and their use

LERCHEN HANS-GEORG

Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders

Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders

Dipeptoid prodrugs and the use thereof

Dipeptoid prodrugs and the use thereof

THEDE KAI

Substituted dihydropyrazolones for treating cardiovascular and hematological diseases

Substituted dihydropyrazolones for treating cardiovascular and hematological diseases

NELL PETER

Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof

Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof

WUNBERG TOBIAS

Substituted dihydroquinazolines

VAKALOPOULOS ALEXANDROS

Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs

MEIER HEINRICH

Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors

BRUEGGEMEIER ULF

Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof

FURSTNER CHANTAL

Bisaryl-bonded aryltriazolones and use thereof

AICURIS GMBH & CO KG

Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents

FÜRSTNER CHANTAL

Substituted N-phenethyltriazoloneacetamides and use thereof